NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing financing and advisory services to emerging growth companies worldwide, today confirmed that over 135 leading biotechnology, specialty pharma and medical technology companies will be featured at its 23rd Annual OC Growth Stock Conference. This invitation-only conference with more than 430 presenting companies will be held March 13-16, 2011 at The Ritz Carlton, located at 1 Ritz Carlton Drive, Dana Point, California.
“As one of the largest and fastest growing sectors of the economy, the healthcare sector is highly attractive to investors seeking outsized returns. The sector overall has benefitted from increased investor interest and heightened capital markets activity throughout 2010, which we see continuing into 2011,” said John Chambers, ROTH Managing Director and Head of Healthcare Investment Banking. “This conference serves as an ideal venue for company management to interact with the investors that will provide both capital and support as they continue to grow, and for investors to explore the opportunities being targeted by an extremely innovative group of select companies.”
Since January 2010, ROTH has executed approximately 46 healthcare financings, raising over $1 billion for its clients, and has significantly increased its market position in funding life sciences companies.
Scott Henry, CFA, Head of Healthcare Research at ROTH, said, "Our annual conference provides investors unparalleled access to company management and the opportunity to hear about the latest innovations from a wide spectrum of cutting-edge companies spanning the life sciences sector. Participants can attend one-on-one sessions, moderated company presentations and interactive panels led by industry professionals, clinical experts and academics. In addition, the unique conference setting and agenda, which includes evening programs, is highly conducive to the fostering of informal interactions and discussions among attendees."
This year’s featured healthcare panel sessions will be on “Hot Targets in Oncology”, held on Monday, March 14th, and “Antibacterials”, held on Tuesday March 15th.
The three-day, institutional investor conference will be the largest ROTH conference to date and feature management presentations from companies representing a broad spectrum of sectors including: Healthcare, Media & Internet, Enterprise Software, Gaming, Semiconductors, Global Energy and Industrials and Retail & Consumer. The agenda will also include a China Track with over 100 China-based companies represented.
A partial list of conference sponsors at the time of this announcement includes:
|AFH Holding & Advisory|
|DLA Piper US LLP|
|Loeb & Loeb|
|Lowenstein Sandler PC|
|Marcum Bernstein & Pinchuk LLP|
|William O'Neil + Co|
|Anslow + Jaclin LLP|
|Goodwin Procter LLP|
|Latham & Watkins LLP|
|OTC Markets Inc.|
|Pillsbury Winthrop Shaw Pittman LLP|
|Sichenzia Ross Friedman Ference LLP|
|Stradling Yocca Carlson & Rauth|
|CCG Investor Relations|
|Continental Stock Transfer & Trust Company|
|Corporate Stock Transfer|
|Dorsey & Dorsey|
|EFP Rotenberg LLP|
|Grant Thornton LLP|
|Holtz Rubenstein Reminick LLP|
|Mayer Hoffman McCann P.C.|
|Stroock & Stroock & Lavan LLP|
|The Piacente Group, Inc.|
|Wall Street Webcasting|
|Weinberg & Company|
|Weintraub Genshlea Chediak|
|Winston & Strawn LLP|
For more information about this invitation-only conference – including agenda, web cast schedule and a list of participating companies – please visit: www.roth.com.
About Roth Capital Partners, LLC:
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on identifying opportunities for institutional investors in U.S.-listed equity securities of companies based in the U.S. and China. Headquartered in Newport Beach, CA, with offices throughout the U.S., Hong Kong and a Shanghai Representative Office, the employee-owned firm provides analytical research, trading, capital raising, and business combination advisory services. ROTH seeks to implement innovative financing strategies to efficiently meet the liquidity and valuation requirements of both its corporate and institutional investor clients.